Concepedia

Anna‐Katharina Müller

AM

4

Publications

160

Citations

4

H-Index

2017

Active since

Affiliations

Weizmann Institute of Science(Current)

Anna‐Katharina Müller is an author at Weizmann Institute of Science specializing in breast cancer, oncology, and medicine.

Top concepts

Publications per year

2017–2020

4

Publications

4

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein

Amir Kedan, Nandini Verma, Ashish Saroha et al. · Cell Death and Disease · 2018 · 66 citations · Full text

Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer

Sung‐Young Shin, Anna‐Katharina Müller, Nandini Verma et al. · PLoS Computational Biology · 2018 · 34 citations · Full text

, , +18

Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance

Fabienne Lamballe, Fahmida Ahmad, Yaron Vinik et al. · Advanced Science · 2020 · 34 citations · Full text

Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells

Effrosini Panayotopoulou, Anna‐Katharina Müller, Melanie Börries et al. · Oncotarget · 2017 · 26 citations · Full text

, , +19

Rows per page

1–4 of 4